|
Volumn , Issue 3, 2005, Pages
|
High dose chemotherapy and autologous bone marrow or stem cell transplantation versus conventional chemotherapy for women with early poor prognosis breast cancer.
a a a a |
Author keywords
[No Author keywords available]
|
Indexed keywords
ANTINEOPLASTIC AGENT;
AUTOTRANSPLANTATION;
BONE MARROW TRANSPLANTATION;
BREAST TUMOR;
CLINICAL TRIAL;
CONTROLLED CLINICAL TRIAL;
FEMALE;
HUMAN;
META ANALYSIS;
MORTALITY;
MULTIMODALITY CANCER THERAPY;
RANDOMIZED CONTROLLED TRIAL;
REVIEW;
STEM CELL TRANSPLANTATION;
SURVIVAL RATE;
ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS;
BONE MARROW TRANSPLANTATION;
BREAST NEOPLASMS;
COMBINED MODALITY THERAPY;
FEMALE;
HUMANS;
RANDOMIZED CONTROLLED TRIALS;
STEM CELL TRANSPLANTATION;
SURVIVAL RATE;
TRANSPLANTATION, AUTOLOGOUS;
|
EID: 32944460893
PISSN: None
EISSN: 1469493X
Source Type: Journal
DOI: None Document Type: Review |
Times cited : (33)
|
References (38)
|